Laser Therapy for Scarring and Fibrosis in Amputees
(LASER Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests whether a laser treatment can help amputees with painful scars wear their prosthetic legs more comfortably. Many veterans with lower limb amputations face skin problems, such as scars, that make using prosthetics difficult. The trial aims to determine if fractional laser therapy (Fractional CO2 Laser Ablative Resurfacing), a skin treatment for scars, can provide lasting relief. The study seeks veterans who regularly use prosthetic legs but struggle due to scarring or other skin issues. As an unphased trial, it offers veterans a chance to explore new solutions for improved comfort with their prosthetics.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.
What prior data suggests that fractional laser therapy is safe for scar treatment in amputees?
Research has shown that fractional CO2 laser resurfacing is generally safe for treating scars. Studies have found it effective for scars from burns and injuries. This treatment typically results in fewer side effects and a quicker recovery time compared to older laser methods.
One study found that this laser treatment improved the thickness and symptoms of burn scars. Another study suggested it is effective and safe, enhancing quality of life. Although multiple sessions may be necessary, the treatment is well-tolerated and widely used for skin issues.
Overall, fractional CO2 laser therapy appears to be a reliable option with a good safety record.12345Why are researchers excited about this trial?
Unlike the standard treatments for scarring and fibrosis, which often involve topical creams or surgical revision, fractional CO2 laser therapy is unique because it uses precise laser technology to resurface the skin and promote healing at a cellular level. This laser method can precisely target scar tissue, encouraging new collagen formation and improving skin texture and appearance. Researchers are excited about this approach because it offers a non-invasive option with the potential for quicker recovery and more effective results in improving quality of life for amputees.
What evidence suggests that fractional laser therapy might be an effective treatment for scarring and fibrosis in amputees?
Studies have shown that fractional CO2 laser therapy effectively treats scars, including those from surgery and acne. This laser treatment creates tiny wounds in the skin, promoting healing and collagen production, which reduces scar appearance. Research indicates that this method involves less recovery time and fewer side effects than older laser techniques. Patients often experience significant improvements in skin texture and flexibility. In this trial, all participants will receive fractional CO2 laser therapy to assess its impact on scars, quality of life, and function. These findings suggest that fractional CO2 laser therapy could be a promising option for improving scar-related issues in amputees, potentially making prosthetic limb use more comfortable.678910
Who Is on the Research Team?
Jeffrey T Heckman, DO
Principal Investigator
James A. Haley Veterans' Hospital, Tampa, FL
Are You a Good Fit for This Trial?
This trial is for Veterans aged 21-70 with lower limb amputations who regularly use prostheses but experience discomfort due to scarring. Participants must understand the study, attend sessions, and have skin issues treatable by laser therapy. Those without prosthesis-related skin problems or with open wounds/infections are excluded.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Pre-procedural Assessment
Participants undergo pre-procedural assessment including subjective and objective measures to evaluate functional mobility, socket comfort, prosthetic history, health-related quality of life, and residual limb measures.
Treatment
Participants receive fractionated CO2 laser therapy from a credentialed dermatologist.
Follow-up
Participants are monitored for safety and effectiveness after treatment with follow-up visits to repeat outcome measures.
What Are the Treatments Tested in This Trial?
Interventions
- Fractional CO2 Laser Ablative Resurfacing
Find a Clinic Near You
Who Is Running the Clinical Trial?
VA Office of Research and Development
Lead Sponsor
Miami Dermatology and Laser Institute
Collaborator
Bruce W. Carter VA Medical Center
Collaborator